Botulinum neurotoxin formulations: overcoming the confusion [Corrigendum]
Samizadeh S, De Boulle K. Clin Cosmet Investig Dermatol. 2018;11:273–287.On page 273, Introduction section, line 5, the sentence “The human nervous system is susceptible to BoNT-A, B, C, E, F, and G and unaffected by D.1,4–6” should be changed to “Th...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Dove Medical Press,
2018-12-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Samizadeh S, De Boulle K. Clin Cosmet Investig Dermatol. 2018;11:273–287.On page 273, Introduction section, line 5, the sentence “The human nervous system is susceptible to BoNT-A, B, C, E, F, and G and unaffected by D.1,4–6” should be changed to “The human nervous system is susceptible to BoNT-A, B, C, E, F, and G and almost unaffected by D.1,4–6,131”. On page 273, Introduction section, line 11, “BoNTs” should be changed to “botulinum toxins”. On page 276, Table 2, Storage conditions column, “Below 8°C” should be changed to “2°C–8°C”. Read the original article |
|---|---|
| Item Description: | 1178-7015 |